ID: ALA278301

Max Phase: Preclinical

Molecular Formula: C43H63F3N6O9

Molecular Weight: 750.98

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1[nH]c2ccc(OCCCCCN)cc2c1CCCCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C41H62N6O7.C2HF3O2/c1-5-27(4)36(39(50)46-35(41(52)53)23-26(2)3)47-38(49)34(24-28-14-16-29(48)17-15-28)45-40(51)37-31(13-9-6-7-10-20-42)32-25-30(18-19-33(32)44-37)54-22-12-8-11-21-43;3-2(4,5)1(6)7/h14-19,25-27,34-36,44,48H,5-13,20-24,42-43H2,1-4H3,(H,45,51)(H,46,50)(H,47,49)(H,52,53);(H,6,7)/t27-,34-,35-,36-;/m0./s1

Standard InChI Key:  BZLLPRXAHOVPHB-AWAWMKESSA-N

Associated Targets(Human)

NTSR2 Tchem Neurotensin receptor (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ntsr1 Neurotensin receptor 1 (196 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 750.98Molecular Weight (Monoisotopic): 750.4680AlogP: 4.93#Rotatable Bonds: 25
Polar Surface Area: 221.89Molecular Species: ZWITTERIONHBA: 8HBD: 8
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.11CX Basic pKa: 10.54CX LogP: 2.05CX LogD: 0.58
Aromatic Rings: 3Heavy Atoms: 54QED Weighted: 0.05Np Likeness Score: 0.06

References

1. Dood DS, Kozikowski AP, Cusack B, Richelson E.  (1994)  Synthesis of partially non-peptidic neurotensin mimetics,  (10): [10.1016/S0960-894X(01)80338-3]

Source